Project Grant F31AA031397

Award Date 1/26/25
Completion Date 8/31/27
Dollars Obligated $98K
Federal Grant Program
93.273
Assistance Type
Project Grant
Place of Performance
Pittsburgh, PA 15260, USA
Similar Awards
This Project Grant award from the National Institute on Alcohol Abuse and Alcoholism (NIAAA), under the federal Alcohol Research Programs (CFDA 93.273), provides $223,932 to Trustees of Indiana University (Indianapolis) to study the neural circuit mechanisms underlying impulsivity and how they are altered by genetic risk for excessive drinking. The overarching goal is to identify how parvalbumin interneurons in the dorsomedial prefrontal cortex (DMPFC) regulate impulsive decision-making, and...
This federal Project Grant award from the National Institute on Alcohol Abuse and Alcoholism (NIAAA), under the Alcohol Research Programs (CFDA 93.273) grant program, will support research to investigate the role of sex chromosomes in alcohol drinking behaviors. The total award amount is $321,102 and the project will run from August 1, 2024 to July 31, 2029. The key objectives of the research are to: 1) demonstrate that alcohol consumption is reduced in mice with two X chromosomes compared to...
This Project Grant award in the amount of $404,508.00 was provided by the National Institute on Alcohol Abuse and Alcoholism (NIAAA) under the Alcohol Research Programs (CFDA 93.273) federal grant program. The award aims to examine interleukin-1β (IL-1β) synaptic regulation and its role in cognitive impairment during early withdrawal and protracted abstinence from chronic alcohol exposure in male and female mice. The overarching goal is to determine the neuroimmune mechanisms by which chronic...
This federal Project Grant award from the National Institute on Alcohol Abuse and Alcoholism (NIAAA), under the Alcohol Research Programs (CFDA 93.273), provides $506,472 to The Pennsylvania State University to investigate sex differences in somatostatin cell dynamics and exploratory behavior after adolescent binge drinking in mice. The research aims to 1) examine the contributions of L-type calcium channels as a mechanism through which somatostatin cells are altered due to adolescent alcohol...
This Project Grant award for $545,282 from the National Institute on Alcohol Abuse and Alcoholism (NIAAA), under the Alcohol Research Programs (CFDA 93.273) federal grant program, aims to investigate neural mechanisms associated with cognitive reappraisal and alcohol cue reactivity in individuals with alcohol use disorder (AUD) during early abstinence. The key objectives are to: 1) determine how neural mechanisms related to reappraisal and alcohol cue-reactivity change across early abstinence...
This Project Grant award from the National Institute on Alcohol Abuse and Alcoholism (NIAAA), under the Alcohol Research Programs (CFDA 93.273) federal grant program, will provide $221,375 to Oregon Health & Science University (OHSU) to investigate the role of the anterior olfactory system in regulating alcohol consumption. The key objectives are to examine whether chemogenetic activation of oxytocin receptor (OXTR)-containing neurons in the anterior olfactory nucleus (AON) and vasopressin...
The University of Texas Health Science Center at San Antonio received a $146,816 Project Grant from the National Institute on Alcohol Abuse and Alcoholism (CFDA 93.273 Alcohol Research Programs) to conduct research on the mechanisms by which alcohol disrupts astrocytic control of neuronal excitability. The research aims to identify molecular mechanisms that could lead to new treatments for alcohol use disorder (AUD). Specifically, the project will: 1) Determine if astrocytic FOLH1 contributes to...
The National Institute on Alcohol Abuse and Alcoholism (NIAAA), under the Alcohol Research Programs (CFDA 93.273), awarded a 5-year, $388,800 Project Grant to The Trustees of Columbia University in the City of New York to investigate the neural mechanisms underlying anxiety during early and prolonged abstinence in individuals with Alcohol Use Disorder (AUD). The research aims to train the principal investigator, Dr. Srivastava, in clinical trials methodology, fMRI techniques, addiction...
This Project Grant award from the National Institute on Alcohol Abuse and Alcoholism (NIAAA), under the Alcohol Research Programs (CFDA 93.273), provides $509,683.37 in funding to the University of Missouri System to conduct research on the neurobehavioral mechanisms underlying alcohol use disorder (AUD). The research program aims to translate a preclinical model of individual differences in the attribution of incentive salience to reward-predictive cues into a human laboratory model examining...
This Project Grant award of $594,784 from the National Institute on Alcohol Abuse and Alcoholism (NIAAA) under the Alcohol Research Programs (CFDA 93.273) will fund a postmortem, multi-omic study of brains from 341 total subjects to identify novel lasting transcriptomic and epigenetic changes in biological pathways that may serve as biomarkers and therapeutic targets for alcohol use disorder (AUD). The research will analyze RNA sequencing and whole-genome bisulfite sequencing data across 8 brain...

INPUT SPECIFIC ADAPTATIONS TO GLUTAMATERGIC STRENGTH AND PLASTICITY ON PFC PV-INS FOLLOWING ETHANOL DRINKING - PROJECT SUMMARY/ABSTRACT: ALTHOUGH BOTH MEN AND WOMEN ARE AFFECTED BY ALCOHOL USE DISORDER (AUD), WOMEN OFTEN PROGRESS THROUGH AUD DISEASE MILESTONES FASTER AND EXPERIENCE MORE SEVERE HEALTH CONSEQUENCES THAN MEN. ONE KEY BRAIN REGION ASSOCIATED WITH AUD IS THE PREFRONTAL CORTEX (PFC), A STRUCTURE ASSOCIATED WITH DEFICITS IN MODERATING DRINKING BEHAVIORS. PREVIOUS FINDINGS FROM OUR LAB DEMONSTRATE THAT PARVALBUMIN-EXPRESSING INHIBITORY INTERNEURONS (PV-INS), A KEY SUBPOPULATION OF GABAERGIC CELLS WITHIN PFC, DISPLAY BASAL SEX DIFFERENCES IN MEMBRANE PHYSIOLOGY AND UNDERGO SEX-DEPENDENT ADAPTATIONS IN SYNAPTIC STRENGTH FOLLOWING CHRONIC DRINKING. IN RECENT YEARS, THE METABOTROPIC GLUTAMATE (MGLU) RECEPTOR SUBTYPE 5 HAS EMERGED AS A PROMISING THERAPEUTIC TARGET FOR THE TREATMENT OF AUD. THE MGLU5 RECEPTOR IS HIGHLY EXPRESSED ON PFC PV-INS AND HAS BEEN IMPLICATED IN MEDIATING ETHANOL SEEKING ACROSS SEVERAL RODENT MODELS OF AUD. HOWEVER, LIMITED CLINICAL SUCCESS OF COMPOUNDS THAT INHIBIT MGLU5 RECEPTORS NECESSITATES A MORE PRECISE UNDERSTANDING OF THE CIRCUITS AND SYNAPTIC MECHANISMS THROUGH WHICH MGLU5 RECEPTORS REGULATE DRINKING BEHAVIORS. MY PRELIMINARY DATA SUGGESTS THAT MGLU5 RECEPTORS SEX-DEPENDENTLY REGULATE SYNAPTIC TRANSMISSION AND ENDOCANNABINOID PLASTICITY ONTO PFC PV-INS. IN THIS PROPOSAL I WILL USE EX VIVO SLICE ELECTROPHYSIOLOGY, VIRAL-MEDIATED OPTOGENETIC TOOLS, AND RNASCOPE TO TEST THE HYPOTHESIS THAT DISTINCT EXCITATORY INPUTS ONTO PV-INS ARE REGULATED BY MGLU5 RECEPTOR SIGNALING, AND THAT CHRONIC DRINKING FUNCTIONALLY ALTERS THESE INPUTS AND MGLU5 RECEPTOR FUNCTION. THIS PROPOSAL WILL SPECIFICALLY ASSESS GLUTAMATERGIC AFFERENTS FROM THE BASOLATERAL AMYGDALA (BLA) AND MEDIODORSAL THALAMUS (MDT), WHICH PREFERENTIALLY TARGET PV-INS TO DRIVE ROBUST FEEDFORWARD INHIBITION IN THE PFC. IN BOTH HUMAN AND ANIMAL STUDIES, ACUTE AND CHRONIC ETHANOL EXPOSURE ALTERS GLUTAMATE TRANSMISSION IN THE BLA AND MDT. HOWEVER, DIFFERENCES IN SUBCELLULAR LOCALIZATION AND EXPRESSION OF CB1 RECEPTORS MAY SUGGEST THAT EACH OF THESE EXCITATORY INPUTS HAVE DIFFERENT FUNCTIONS AT PFC PV-INS FROM MALE AND FEMALE MICE. IN AIM 1, I WILL DETERMINE WHETHER MGLU5 RECEPTORS REGULATE EXCITATORY TRANSMISSION (1.1) AND ENDOCANNABINOID PLASTICITY (1.2) AT BLA AND MDT SYNAPSES ON PFC PV-INS IN A SEX-SPECIFIC MANNER. IN AIM 2, I WILL DETERMINE WHETHER CHRONIC DRINKING SEX-DEPENDENTLY ALTERS BLA AND MDT SYNAPTIC STRENGTH (2.1) AND MGLU5 RECEPTOR SIGNALING ON PFC PV-INS (2.2). PRELIMINARY DATA INDICATE FEMALE (BUT NOT MALE) MICE WITH A GENETIC DELETION OF MGLU5 FROM PV+ CELLS DRINK LESS WHEN PROVIDED IA ETHANOL. IN AIM 3, I WILL DETERMINE WHETHER PFC PV-INS MEDIATE BINGE-DRINKING IN PV-MGLU5-/- MICE. THE RESULTS OF THESE EXPERIMENTS WILL IMPROVE OUR UNDERSTANDING OF THE MOLECULAR COMPONENTS UNDERLYING ETHANOL-INDUCED ADAPTATIONS IN SYNAPTIC PLASTICITY AT SPECIFIC PFC INPUTS AND MAY DIRECT THERAPEUTIC INTERVENTIONS FOR THE TREATMENT OF AUD. BY COMPLETING THIS PROPOSAL, I WILL HAVE STRENGTHENED MY TECHNICAL SKILLS, ENHANCED MY KNOWLEDGE, AND RECEIVED PROFESSIONAL DEVELOPMENT NECESSARY FOR MY SUCCESS AS AN INDEPENDENT INVESTIGATOR IN THE FIELD OF ALCOHOL RESEARCH.

Posted 7/26/24, 12:00 AM